Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.

[1]  J. Meza,et al.  Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. , 2001, International journal of radiation oncology, biology, physics.

[2]  M. Stevens,et al.  Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Meza,et al.  Results from the IRS IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma , 2000 .

[4]  S. Donaldson,et al.  Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Voûte,et al.  Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. , 1998, European journal of cancer.

[6]  L. Constine,et al.  The future of therapy for childhood rhabdomyosarcoma: clues from molecular biology. , 1995, International journal of radiation oncology, biology, physics.

[7]  E. Gehan,et al.  The Third Intergroup Rhabdomyosarcoma Study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Voûte,et al.  Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E. Gehan,et al.  The intergroup rhabdomyosarcoma study‐II , 1993, Cancer.

[10]  E. Gehan,et al.  Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Gehan,et al.  The intergroup rhabdomyosarcoma study‐I. A final report , 1988, Cancer.

[12]  E. Gehan,et al.  Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Voûte,et al.  [Treatment of orbital rhabdomyosarcoma]. , 1985, Nederlands tijdschrift voor geneeskunde.

[14]  E. Gehan,et al.  Radiotherapy (RT) for rhabdomyosarcoma (RMS) in children: A report from the intergroup rhabdomyosarcoma study #2 (IRS-2) (Funding # CA 24507) , 1984 .

[15]  Soule Eh,et al.  Pathology of rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972-78. , 1981 .

[16]  E. Gehan,et al.  Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma Study. , 1981, National Cancer Institute monograph.

[17]  J. Harry.  Pathology of rhabdomyosarcoma. , 1975, Modern problems in ophthalmology.

[18]  D. Cox,et al.  The analysis of binary data , 1971 .

[19]  H. G. Taylor,et al.  Prognosis in childhood rhabdomyosarcoma , 1970, Cancer.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .